What is leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Leptospirosis?

Leptospirosis is a bacterial zoonotic infection caused by pathogenic Leptospira species that humans acquire through direct contact with urine from infected animals (particularly rats, dogs, cattle) or indirect contact with urine-contaminated water or soil. 1, 2

Transmission and Risk Factors

The disease spreads when leptospires enter the body through:

  • Mucous membranes or skin abrasions after exposure to contaminated water or soil 3
  • Direct contact with infected animal urine from rats (most important source), dogs, cattle, pigs, and other domestic or wild animals 1, 4

High-risk exposures include:

  • Recreational water sports in contaminated fresh water 1, 4
  • Occupational exposure in agricultural workers, especially those working in flooded fields or with animals 1, 4
  • Flooding events which dramatically increase transmission risk 4, 5
  • Contact with reproductive materials at live-birthing exhibits involving livestock 1

Clinical Presentation

Biphasic Course

Leptospirosis typically follows a biphasic pattern 1, 2:

Septicemic/Bacteremic Phase (4-7 days):

  • High fever (usually ≥39°C) 2
  • Severe myalgias, especially in the calves 1, 2
  • Headache 2
  • Conjunctival suffusion (highly suggestive finding) 1, 2, 6
  • Chills 6

Immune Phase (follows 1-3 days later):

  • Recurrent fever 1
  • Hepatorenal syndrome 1
  • Hemorrhagic manifestations 1

Disease Severity Spectrum

Mild to Moderate Form (most common):

  • Flu-like symptoms that may be self-limiting 2, 6

Severe Form (Weil's Disease, 5-10% of cases):

  • Jaundice with mild transaminase elevation but high bilirubin 1, 2
  • Acute kidney failure (hepatorenal syndrome) 1, 2
  • Hemorrhagic complications due to capillary fragility (clotting tests often normal) 1
  • Severe pulmonary hemorrhage syndrome (>50% fatality rate) 7
  • Multisystem organ failure 7

Diagnostic Approach

Initial Laboratory Findings (Non-specific)

  • Urinalysis: Proteinuria and hematuria 1, 2
  • Complete blood count: Polymorphonuclear leukocytosis, thrombocytopenia, anemia if hemorrhage present 1, 2
  • Liver function: High bilirubin with mild transaminase elevation 1, 2
  • Renal function: Evidence of renal failure 1, 2

Confirmatory Testing

Serological Testing (most common method): 1, 2

  • IgM titer >1:320 is suggestive of leptospirosis 1, 2
  • IgM titer 1:80 to 1:160 consistent with early infection but may represent cross-reactions 1, 2
  • Convalescent serology (>10 days after symptom onset) for IgM ELISA and microscopic agglutination test (MAT) 1, 2
  • Earliest positive results appear 6-10 days after symptom onset 1

Culture: 1, 2

  • Blood cultures (taken within first 5 days before antibiotics, kept at room temperature) 1, 2
  • CSF cultures can be sent to reference laboratories 1
  • Urine is NOT suitable for leptospira isolation 1

Confirmed Case Definition: 6

  • Isolation of Leptospira from clinical specimen, OR
  • Fourfold or greater increase in agglutination titer between acute and convalescent sera, OR
  • Demonstration of Leptospira by immunofluorescence 6

Treatment

Antibiotic Therapy

For Mild to Moderate Disease:

  • Start treatment immediately upon clinical suspicion without waiting for laboratory confirmation 2, 6
  • Penicillin or doxycycline are effective during the bacteremic phase 1, 2, 8
  • Early mild disease is generally self-limiting 1

For Severe Disease (Weil's Disease):

  • Initiate antibiotics within the first hour of recognition 2
  • Standard course: 7 days, may extend to 10 days with slow clinical response 2
  • Treatment initiated after 4 days of symptoms may be less effective 2
  • Continue full course even with clinical improvement 2

Critical Management Considerations

A systematic review showed no benefit for antibiotics in established severe leptospirosis based on three trials, as severe disease is likely immunologically mediated; however, most infectious disease specialists continue to recommend antibiotics pending further evidence. 1

Patients with Weil's disease require:

  • Renal support (prompt dialysis for oliguric renal failure) 7
  • Liver support 1
  • Fluid resuscitation targeting systolic BP >90 mmHg in adults 2
  • ICU admission for persistent tissue hypoperfusion despite initial resuscitation 2

Prevention

Primary Prevention Measures: 4, 6

  • Avoid contact with potentially contaminated water, especially during floods 4
  • Use protective clothing during occupational or recreational water exposure 8
  • Avoid contact with urine from infected animals 2, 6

Chemoprophylaxis:

  • Doxycycline once weekly provides short-term protection in high-risk environments 8
  • Mass prophylaxis campaigns have been deployed during outbreak situations following severe flooding 5

Common Pitfalls

  • Misdiagnosis as viral hepatitis in patients presenting with fever and jaundice—always consider leptospirosis in the differential 2
  • Delaying treatment while awaiting laboratory confirmation—treat on clinical suspicion as delay increases mortality 2
  • Assuming normal clotting tests exclude hemorrhagic complications—bleeding is due to capillary fragility, not coagulopathy 1
  • Overlooking conjunctival suffusion—this highly suggestive sign should prompt immediate consideration of leptospirosis 1, 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Leptospirosis Classification and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathology and pathogenesis of human leptospirosis: a commented review.

Revista do Instituto de Medicina Tropical de Sao Paulo, 2018

Guideline

Leptospirosis Transmission and Prevention in India

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Leptospirosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Leptospirosis in humans.

Current topics in microbiology and immunology, 2015

Research

Prevention and treatment of leptospirosis.

Expert review of anti-infective therapy, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.